U.S. Research Roundup-Adobe, Braveheart Bio, CACI International

| | | --- | | * Abercrombie & Fitch Co. ANF.N: Argus Research raises to buy from hold | | * Adobe Inc ADBE.O: Jefferies raises target price to $285 from $230 | | * Braveheart Bio, Inc. BRVE.O: Jefferies initiates coverage with buy rating | | * CACI International Inc CACI.N: TD Cowen raises target price to $700 from $550 | | * Edison International EIX.N: Mizuho cuts to neutral from outperform | Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order. | | | --- | | * Abercrombie & Fitch Co. ANF.N: Argus Research raises to buy from hold | | * Adobe Inc ADBE.O: Jefferies raises target price to $285 from $230 | | * Affirm Holdings, Inc. AFRM.O: Bernstein raises target price to $110 from $100 | | * Airjoule Technologies Corporation AIRJ.O: Needham initiates coverage with hold rating | | * ATI Inc ATI.N: TD Cowen raises target price to $250 from $210 | | * Attovia Therapeutics ATTO.O: Leerink Partners initiates coverage with outperform rating | | * Attovia Therapeutics ATTO.O: Leerink Partners initiates coverage with target price $52 | | * Autodesk, Inc. ADSK.O: Citigroup raises target price to $276 from $269 | | * Babcock & Wilcox Enterprises, Inc. BW.N: Needham initiates coverage with buy rating | | * Babcock & Wilcox Enterprises, Inc. BW.N: Needham initiates coverage with PT $20 | | * Braveheart Bio Inc BRVE.O: Jefferies initiates coverage with buy rating | | * Braveheart Bio Inc BRVE.O: Jefferies initiates coverage with target price $48 | | * Braveheart Bio, Inc. BRVE.O: Stifel initiates coverage with buy rating; target price $45 | | * Braveheart Bio, Inc. BRVE.O: TD Cowen initiates coverage with buy rating | | * BRC Inc BRCC.N: D.A. Davidson adjusts target price to $25 from $2.5 to reflect 1-for-10 reverse stock split | | * Burlington Stores, Inc. BURL.N: Deutsche Bank cuts target price to $323 from $367 | | * CACI International Inc CACI.N: TD Cowen raises target price to $700 from $550 | | * Deere & Co DE.N: Raymond James raises target price to $730 from $700 | | * Dollar Tree Inc DLTR.O: Piper Sandler raises target price to $121 from $114 | | * Edison International EIX.N: Mizuho cuts target price to $70 from $86 | | * Edison International EIX.N: Mizuho cuts to neutral from outperform | | * Entergy ETR.N: Jefferies cuts target price to $133 from $139 | | * Five9, Inc. FIVN.O: Truist Securities raises target price to $40 from $35 | | * Healthequity HQY.O: Deutsche Bank raises target price to $142 from $135 | | * Honeywell Aerospace Inc HONA.O: TD Cowen cuts target price to $180 from $250 | | * IBM IBM.N: Susquehanna raises target price to $235 from $225 | | * Intercontinental Exchange Inc ICE.N: Jefferies raises target price to $189 from $171 | | * Mongodb, Inc. MDB.O: Monness Crespi Hardt raises target price to $460 from $415 | | * Omega Healthcare Investors, Inc. OHI.N: Mizuho raises target price to $46 from $45 | | * PayPal PYPL.O: Clear Street cuts target price to $55 from $61 | | * PayPal PYPL.O: Mizuho cuts target price to $51 from $60 | | * PayPal PYPL.O: Truist Securities cuts target price to $53 from $62 | | * PG&E Corp PCG.N: BMO cuts target price to $21 from $28 | | * PG&E Corp PCG.N: BMO cuts to market perform from outperform | | * PG&E Corp PCG.N: Mizuho cuts to neutral from outperform; cuts PT to $16 from $21 | | * Popular, Inc BPOP.O: Benchmark raises target price to $216 from $214 | | * Protagonist Therapeutics Inc PTGX.O: Jefferies raises target price to $171 from $169 | | * Revolution Medicines, Inc. RVMD.O: Needham raises target price to $275 from $240 | | * Rubrik Inc RBRK.N: CIBC raises target price to $120 from $115 | | * Rubrik, Inc. RBRK.N: Citigroup raises target price to $130 from $96 | | * Sabra Health Care Reit, Inc. SBRA.O: Mizuho raises target price to $21 from $20 | | * Salesforce, Inc. CRM.N: Argus Research raises target price to $300 from $290 | | * Scribe Therapeutics Inc. SCTX.O: H.C. Wainwright initiates coverage with target price $60 | | * Scribe Therapeutics Inc. SCTX.O: H.C. Wainwright initiates coverage with buy rating | | * Sempra SRE.N: Mizuho cuts to neutral from outperform; cuts target price to $84 from $104 | | * T. Rowe Price Group, Inc. TROW.O: TD Cowen raises target price to $110 from $108 Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Adobe, Braveheart Bio and CACI International, on Monday.

U.S. Research Roundup-Adobe, Braveheart Bio, CACI International

Reuters-reported highlights

Wall Street analyst actions

Related News

SailPoint expands CrowdStrike partnership with Falcon Next-Gen SIEM integration

Zenas BioPharma highlights FDA review acceptance for obexelimab IgG4-RD filing in corporate presentation

Bessent says Iran is lashing out amid economic pressure of sanctions

Choice Hotels names Dominic Dragisich CEO, adds him to board

Bio-Rad CFO Lakkaraju joins Wells Fargo Healthcare Conference fireside chat